Axially Chiral Cannabinols: A New Platform for Cannabinoid-Inspired Drug Discovery

ChemMedChem. 2020 May 6;15(9):728-732. doi: 10.1002/cmdc.202000025. Epub 2020 Mar 16.

Abstract

Phytocannabinoids (and synthetic analogs thereof) are gaining significant attention as promising leads in modern medicine. Considering this, new directions for the design of phytocannabinoid-inspired molecules is of immediate interest. In this regard, we have hypothesized that axially-chiral-cannabinols (ax-CBNs), unnatural and unknown isomers of cannabinol (CBN) may be valuable scaffolds for cannabinoid-inspired drug discovery. There are two main factors directing our interest to these scaffolds: (a) ax-CBNs would have ground-state three-dimensionality; ligand-receptor interactions can be more significant with complimentary 3D-topology, and (b) ax-CBNs at their core structure are biaryl molecules, generally attractive platforms for pharmaceutical development due to their ease of functionalization and stability. Herein we report a synthesis of ax-CBNs, examine physical properties experimentally and computationally, and perform a comparative analysis of ax-CBN and THC in mice behavioral studies.

Keywords: atropisomerism; axial chirality; cannabinoids; cannabinol; total synthesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / chemical synthesis
  • Analgesics / chemistry
  • Analgesics / pharmacology*
  • Animals
  • Behavior, Animal / drug effects*
  • Cannabinol / chemical synthesis
  • Cannabinol / chemistry
  • Cannabinol / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Mice
  • Molecular Structure

Substances

  • Analgesics
  • Cannabinol